Trial intelligence / Profile preview

Oxytocin and Affective Functioning in PTSD

NCT02546570Phase 2Completed

Sponsor
Yale University
Start
Aug 2015
Primary completion
Aug 2016
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of oxytocin in post-traumatic stress disorder (PTSD), sponsored by Yale University. Started Aug 2015; status: completed.

02

Drugs

oxytocin
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT02546570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02546570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call